“One particular protein plays a crucial role in inflammation. So in our research we are developing an innovative DNA enzyme that prevents high levels of this protein to tackle the inflammation,” states Dr. Veedu from Murdoch University in Australia. With only a$75,000 grant, Drs. Veedu and Wilson are attempting to develop a new, safer, easier to administer drug to combat MS side effects by controlling the inflammation byway of limiting the amount of this protein in one’s body.

Learn more at: http://www.abc.net.au/news/2016-03-15/new-drug-to-reduce-ms-side-effects-in-development/7246438.